Development of an in vitro test procedure for the characterization of left atrial appendage occluder devices
The implantation of an occluder in the left atrial appendage (LAA) is an emerging therapy for the treatment of patients suffering from atrial fibrillation and with a contraindication to oral anticoagulation. The LAA occluder (LAAO) provides a reduction of the potential risk of strokes by thromboembo...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2019-09-01
|
Series: | Current Directions in Biomedical Engineering |
Subjects: | |
Online Access: | https://doi.org/10.1515/cdbme-2019-0116 |
id |
doaj-813b57d5863d4ed0a584f4dd003794d9 |
---|---|
record_format |
Article |
spelling |
doaj-813b57d5863d4ed0a584f4dd003794d92021-09-06T19:19:27ZengDe GruyterCurrent Directions in Biomedical Engineering2364-55042019-09-015146146310.1515/cdbme-2019-0116cdbme-2019-0116Development of an in vitro test procedure for the characterization of left atrial appendage occluder devicesBorowski Finja0Kaule Sebastian1Siewert Stefan2Schmitz Klaus-Peter3Stiehm Michael4Öner Alper Ö5Grabow Niels6Schmitz Klaus-Peter7Institute for ImplantTechnology and Biomaterials e.V., Friedrich-Barnewitz- Straße 4, Rostock-Warnemünde, GermanyInstitute for ImplantTechnology and Biomaterials e.V., Rostock-Warnemünde, GermanyInstitute for ImplantTechnology and Biomaterials e.V., Rostock-Warnemünde, GermanyInstitute for ImplantTechnology and Biomaterials e.V., Rostock-Warnemünde, GermanyInstitute for ImplantTechnology and Biomaterials e.V., Rostock-Warnemünde, GermanyDepartment of Cardiology Rostock University Medical Center,Rostock, GermanyInstitute for Biomedical Engineering, Rostock University Medical Center,Rostock, GermanyInstitute for Biomedical Engineering, Rostock University Medical Center,Rostock, GermanyThe implantation of an occluder in the left atrial appendage (LAA) is an emerging therapy for the treatment of patients suffering from atrial fibrillation and with a contraindication to oral anticoagulation. The LAA occluder (LAAO) provides a reduction of the potential risk of strokes by thromboembolism. Currently, only a few CE-approved devices are available on the market and the number of clinical trials is comparatively low. Furthermore, there is currently no standardized test method available for testing functionality of the occluder, especially for testing safe anchorage and permeability. Therefore, the aim of this study is to establish an in vitro test method to prove anchorage mechanism and permeability regarding thromboembolism of the LAAO under physiological conditions. A standardized technical and fully parameterized silicone model of a LAA, based on studies of different morphologies and sizes, was developed. The LAA model was mounted onto the left atrial chamber of a commercial pulse duplicator system to simulate physiological hemodynamic conditions. The test was performed using the Watchman device (Boston Scientific, USA; size: 31 mm). The inner implantation diameter of the LAA model was designed according to a target compression of 10% for the Watchman device in the implanted configuration. Furthermore, thrombus-like particles (n=150, d=1,7±0,05 mm) were added to represent the flushing of thrombi out of the LAA after device implantation. Within several cycles it was confirmed that no particles were washed out of the LAA model with the implanted occluder leading to a full protection against thromboembolism. It could also be shown that the occluder is firmly anchored in the LAA. Pressure measurements with sensors in the left atrium and in the LAA distal to the occluder could also show that the occluder has no influence on the pressure conditions in the LAA.https://doi.org/10.1515/cdbme-2019-0116laa occlusionin vitro testing |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Borowski Finja Kaule Sebastian Siewert Stefan Schmitz Klaus-Peter Stiehm Michael Öner Alper Ö Grabow Niels Schmitz Klaus-Peter |
spellingShingle |
Borowski Finja Kaule Sebastian Siewert Stefan Schmitz Klaus-Peter Stiehm Michael Öner Alper Ö Grabow Niels Schmitz Klaus-Peter Development of an in vitro test procedure for the characterization of left atrial appendage occluder devices Current Directions in Biomedical Engineering laa occlusion in vitro testing |
author_facet |
Borowski Finja Kaule Sebastian Siewert Stefan Schmitz Klaus-Peter Stiehm Michael Öner Alper Ö Grabow Niels Schmitz Klaus-Peter |
author_sort |
Borowski Finja |
title |
Development of an in vitro test procedure for the characterization of left atrial appendage occluder devices |
title_short |
Development of an in vitro test procedure for the characterization of left atrial appendage occluder devices |
title_full |
Development of an in vitro test procedure for the characterization of left atrial appendage occluder devices |
title_fullStr |
Development of an in vitro test procedure for the characterization of left atrial appendage occluder devices |
title_full_unstemmed |
Development of an in vitro test procedure for the characterization of left atrial appendage occluder devices |
title_sort |
development of an in vitro test procedure for the characterization of left atrial appendage occluder devices |
publisher |
De Gruyter |
series |
Current Directions in Biomedical Engineering |
issn |
2364-5504 |
publishDate |
2019-09-01 |
description |
The implantation of an occluder in the left atrial appendage (LAA) is an emerging therapy for the treatment of patients suffering from atrial fibrillation and with a contraindication to oral anticoagulation. The LAA occluder (LAAO) provides a reduction of the potential risk of strokes by thromboembolism. Currently, only a few CE-approved devices are available on the market and the number of clinical trials is comparatively low. Furthermore, there is currently no standardized test method available for testing functionality of the occluder, especially for testing safe anchorage and permeability. Therefore, the aim of this study is to establish an in vitro test method to prove anchorage mechanism and permeability regarding thromboembolism of the LAAO under physiological conditions. A standardized technical and fully parameterized silicone model of a LAA, based on studies of different morphologies and sizes, was developed. The LAA model was mounted onto the left atrial chamber of a commercial pulse duplicator system to simulate physiological hemodynamic conditions. The test was performed using the Watchman device (Boston Scientific, USA; size: 31 mm). The inner implantation diameter of the LAA model was designed according to a target compression of 10% for the Watchman device in the implanted configuration. Furthermore, thrombus-like particles (n=150, d=1,7±0,05 mm) were added to represent the flushing of thrombi out of the LAA after device implantation. Within several cycles it was confirmed that no particles were washed out of the LAA model with the implanted occluder leading to a full protection against thromboembolism. It could also be shown that the occluder is firmly anchored in the LAA. Pressure measurements with sensors in the left atrium and in the LAA distal to the occluder could also show that the occluder has no influence on the pressure conditions in the LAA. |
topic |
laa occlusion in vitro testing |
url |
https://doi.org/10.1515/cdbme-2019-0116 |
work_keys_str_mv |
AT borowskifinja developmentofaninvitrotestprocedureforthecharacterizationofleftatrialappendageoccluderdevices AT kaulesebastian developmentofaninvitrotestprocedureforthecharacterizationofleftatrialappendageoccluderdevices AT siewertstefan developmentofaninvitrotestprocedureforthecharacterizationofleftatrialappendageoccluderdevices AT schmitzklauspeter developmentofaninvitrotestprocedureforthecharacterizationofleftatrialappendageoccluderdevices AT stiehmmichael developmentofaninvitrotestprocedureforthecharacterizationofleftatrialappendageoccluderdevices AT oneralpero developmentofaninvitrotestprocedureforthecharacterizationofleftatrialappendageoccluderdevices AT grabowniels developmentofaninvitrotestprocedureforthecharacterizationofleftatrialappendageoccluderdevices AT schmitzklauspeter developmentofaninvitrotestprocedureforthecharacterizationofleftatrialappendageoccluderdevices |
_version_ |
1717778512330358784 |